Cambridge Investment Research Advisors’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46K Sell
14,960
-7,100
-32% -$30.8K ﹤0.01% 3865
2025
Q4
$79K Buy
22,060
+955
+5% +$5.85K ﹤0.01% 3724
2025
Q3
$188K Buy
21,105
+1,102
+6% +$11.2K ﹤0.01% 3498
2025
Q2
$184K Sell
20,003
-228,136
-92% -$1.95M ﹤0.01% 3365
2025
Q1
$2.13M Buy
248,139
+164,792
+198% +$1.56M 0.01% 1295
2024
Q4
$895K Buy
83,347
+63,074
+311% +$485K ﹤0.01% 1963
2024
Q3
$115K Buy
20,273
+4,000
+25% +$23.1K ﹤0.01% 3247
2024
Q2
$69K Sell
16,273
-100
-0.6% -$404 ﹤0.01% 3196
2024
Q1
$83K Buy
16,373
+498
+3% +$2.8K ﹤0.01% 3166
2023
Q4
$148K Sell
15,875
-400
-2% -$2.75K ﹤0.01% 2972
2023
Q3
$107K Buy
+16,275
New +$130K ﹤0.01% 2951

Other funds holding AVXL